Concepedia

Author

Denise M. Wolf

University of California, San FranciscoORCID

Also Known As

C. Huertas, Chen, Zhong, D M Wolf, D Wolf, D. M. Wolf, D. Wolf, D.M. Wolf, DENISE M. WOLF, Denise M Wolf, Denise M. Wolf

264

Publications

25.9K

Citations

44

H-Index

77

Concepts

All Affiliations

University of California, San FranciscoThe University of Texas MD Anderson Cancer CenterUniversity of PennsylvaniaUniversity of ChicagoUCSF Helen Diller Family Comprehensive Cancer Center
DM

About

Denise M. Wolf is an author at University of California, San Francisco specializing in medicine, cancer research, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

28

10.7K

2

Natural Sciences

4

4

365

3

Engineering

3

3

1.6K

4

Health Sciences

3

3

78

5

Business

1

1

42

Denise M. Wolf

×

65

Publications

22.9K

Citations

41

H-Index

YearCitations

The Immune Landscape of Cancer

Vésteinn Thórsson, David L. Gibbs, Scott D. Brown,

Immunity

2018

6K

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Jianfang Liu, Tara M. Lichtenberg, Katherine A. Hoadley,

Cell

2018

3.8K

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

Katherine A. Hoadley, Christina Yau, Toshinori Hinoue,

Cell

2018

2.6K

Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin

Katherine A. Hoadley, Christina Yau, Denise M. Wolf,

Cell

2014

1.5K

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

Theo Knijnenburg, Linghua Wang, Michael T. Zimmermann,

Cell Reports

2018

1.2K

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity

Miranda L. Broz, Mikhail Binnewies, Bijan Boldajipour,

Cancer Cell

2014

1.2K

Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma

Edward W. Roberts, Miranda L. Broz, Mikhail Binnewies,

Cancer Cell

2016

974

A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments

Kevin C. Barry, Joy Hsu, Miranda L. Broz,

Nature Medicine

2018

973

Subtype and pathway specific responses to anticancer compounds in breast cancer

Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo,

Proceedings of the National Academy of Sciences

2011

501

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

Mark Jesus M. Magbanua, Lamorna Brown Swigart, H.-T. Wu,

Annals of Oncology

2020

418

Page 1